Grapefruit increases GLP-1 drug levels through CYP3A4 inhibition, but individual risk depends on liver function, other medications, and genetic factors
Helena Teede, PhD, MBBS, director of Monash Universitys Center for Health Research & Implementation and an endocrinologist at Monash Health, led the renaming effort after decades of research
We take the time to understand your specific needs, which allows us to design a peptide therapy plan that is tailored just for you
Always talk to your healthcare provider to choose the best treatment for your health and what you need
Focused on dispensing GLP-1 drugs, the pharmacy will be staffed by clinicians with specialized knowledge in GLP-1s who will provide enhanced guidance and education support to patients
By offering scalable, personalized interventions that empower users to make lasting lifestyle changes, digital health companies can position themselves as key players in the evolving landscape of chronic disease management